Keith Pfister

发表

Inhibition of prenylated KRAS in a lipid environment

Charles A. Wartchow, W. Jahnke, E. Fang, 2017, PloS one.

Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors.

Sean P. Brown, E. Fang, M. Desai, 2019, Bioorganic & medicinal chemistry letters.

4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors.

Z. Ni, D. Bussiere, S. Ramurthy, 2006, Bioorganic & medicinal chemistry letters.

Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5.

E. Altmann, U. Hassiepen, M. Renatus, 2017, Angewandte Chemie.

Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.

Sean P. Brown, Kirk W. Johnson, Z. Ni, 2017, Journal of medicinal chemistry.

Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors.

Sean P. Brown, E. Fang, M. Desai, 2019, Bioorganic & medicinal chemistry letters.

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer.

Simon Ng, Yanchen Zhang, Kenneth Crawford, 2011, ACS medicinal chemistry letters.

Synthesis of cyclic and acyclic enol ethers (vinyl ethers)

P. G. Gassman, S. Burns, Keith Pfister, 1993 .

Biased Complement Diversity Selection for Effective Exploration of Chemical Space in Hit-Finding Campaigns

Johanna M. Jansen, Charles A. Wartchow, Gianfranco De Pascale, 2019, J. Chem. Inf. Model..

Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design.

A. Fanidi, Yu Ding, B. Appleton, 2016, Journal of medicinal chemistry.

Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors.

E. Iwanowicz, Z. Ni, T. Hendrickson, 2011, ACS medicinal chemistry letters.